3
Participants
Start Date
September 20, 2021
Primary Completion Date
December 20, 2023
Study Completion Date
December 20, 2023
ADV7103
Each dose of ADV7103 contains a fixed ratio of 1/3 of ADV7103-CK (potassium citrate) and 2/3 of ADV7103-BK (potassium bicarbonate) based on the mass of active substances. The strength is 6.44 (± 10 %) mEq/g of ADV7103 (alkalinizing power).
Placebo
"Placebo is a combination of 2 mm green coated lactose granules and 2 mm white coated lactose granules to be taken by mouth.~Each dose of placebo contains a fixed ratio of 1/3 of green granules and 2/3 of white granules."
Montefiore Medical Center, The Bronx
The Children's Hospital of Philadelphia, Philadelphia
Emory Children's Center, Atlanta
University of South Florida Pediatric Infectious Disease, Tampa
J.W. Riley Hospital for Children/Indiana University, Indianapolis
Children's Hospital Colorado, Aurora
University of Alberta, Edmonton
The Hospital for Sick Children, Toronto
Lead Sponsor
Advicenne Pharma
INDUSTRY